JP2009539875A5 - - Google Patents

Download PDF

Info

Publication number
JP2009539875A5
JP2009539875A5 JP2009514544A JP2009514544A JP2009539875A5 JP 2009539875 A5 JP2009539875 A5 JP 2009539875A5 JP 2009514544 A JP2009514544 A JP 2009514544A JP 2009514544 A JP2009514544 A JP 2009514544A JP 2009539875 A5 JP2009539875 A5 JP 2009539875A5
Authority
JP
Japan
Prior art keywords
phenyl
chloro
methoxy
thieno
hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009514544A
Other languages
English (en)
Japanese (ja)
Other versions
JP5198439B2 (ja
JP2009539875A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/070662 external-priority patent/WO2007146758A2/en
Publication of JP2009539875A publication Critical patent/JP2009539875A/ja
Publication of JP2009539875A5 publication Critical patent/JP2009539875A5/ja
Application granted granted Critical
Publication of JP5198439B2 publication Critical patent/JP5198439B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009514544A 2006-06-08 2007-06-08 新規なｍｃｈ受容体アンタゴニスト Expired - Fee Related JP5198439B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81184106P 2006-06-08 2006-06-08
US60/811,841 2006-06-08
PCT/US2007/070662 WO2007146758A2 (en) 2006-06-08 2007-06-08 Novel mch receptor antagonists

Publications (3)

Publication Number Publication Date
JP2009539875A JP2009539875A (ja) 2009-11-19
JP2009539875A5 true JP2009539875A5 (cg-RX-API-DMAC7.html) 2010-07-22
JP5198439B2 JP5198439B2 (ja) 2013-05-15

Family

ID=38651254

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009514544A Expired - Fee Related JP5198439B2 (ja) 2006-06-08 2007-06-08 新規なｍｃｈ受容体アンタゴニスト

Country Status (10)

Country Link
US (2) US8263772B2 (cg-RX-API-DMAC7.html)
EP (1) EP2029609A2 (cg-RX-API-DMAC7.html)
JP (1) JP5198439B2 (cg-RX-API-DMAC7.html)
CN (1) CN101454328A (cg-RX-API-DMAC7.html)
AU (1) AU2007257922A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0712680A2 (cg-RX-API-DMAC7.html)
CA (1) CA2652385A1 (cg-RX-API-DMAC7.html)
EA (1) EA015127B1 (cg-RX-API-DMAC7.html)
MX (1) MX2008015662A (cg-RX-API-DMAC7.html)
WO (1) WO2007146758A2 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8546405B2 (en) 2008-12-23 2013-10-01 Abbott Laboratories Anti-viral compounds
SG172352A1 (en) 2008-12-23 2011-07-28 Abbott Lab Anti-viral compounds
US8637678B2 (en) 2008-12-24 2014-01-28 Syngenta Limited Methods for the preparation of aryl amides
US9278922B2 (en) * 2009-04-15 2016-03-08 Abbvie Inc. Anti-viral compounds
EA020031B1 (ru) * 2009-06-11 2014-08-29 Эббви Бахамаз Лтд. Противовирусные соединения
US9394279B2 (en) 2009-06-11 2016-07-19 Abbvie Inc. Anti-viral compounds
US8937150B2 (en) 2009-06-11 2015-01-20 Abbvie Inc. Anti-viral compounds
US8716454B2 (en) 2009-06-11 2014-05-06 Abbvie Inc. Solid compositions
NZ605440A (en) 2010-06-10 2014-05-30 Abbvie Bahamas Ltd Solid compositions comprising an hcv inhibitor
US10201584B1 (en) 2011-05-17 2019-02-12 Abbvie Inc. Compositions and methods for treating HCV
US9034832B2 (en) 2011-12-29 2015-05-19 Abbvie Inc. Solid compositions
WO2013149940A1 (en) 2012-04-02 2013-10-10 Basf Se Acrylamide compounds for combating invertebrate pests
WO2013167633A1 (en) 2012-05-09 2013-11-14 Basf Se Acrylamide compounds for combating invertebrate pests
US11484534B2 (en) 2013-03-14 2022-11-01 Abbvie Inc. Methods for treating HCV
MX394360B (es) 2013-03-14 2025-03-24 Sumitomo Pharma Oncology Inc Inhibidores de jak2 y alk2 y metodos para su uso.
WO2015103490A1 (en) 2014-01-03 2015-07-09 Abbvie, Inc. Solid antiviral dosage forms
AR102849A1 (es) * 2015-03-09 2017-03-29 Astellas Pharma Inc Compuesto de piridina bicíclica
WO2016205590A1 (en) * 2015-06-18 2016-12-22 Cephalon, Inc. Substituted 4-benzyl and 4-benzoyl piperidine derivatives
KR20180026459A (ko) 2015-06-18 2018-03-12 세파론, 인코포레이티드 1,4-치환된 피페리딘 유도체
AU2019310590A1 (en) 2018-07-26 2021-01-14 Sumitomo Pharma Oncology, Inc. Methods for treating diseases associated with abnormal acvr1 expression and acvr1 inhibitors for use in the same
US11192900B2 (en) 2018-10-30 2021-12-07 Nuvation Bio Inc. Substituted 1,6-dihydropyridinones and 1,2-dihydroisoquinolinones as bet inhibitors
KR102677015B1 (ko) 2019-07-02 2024-06-19 누베이션 바이오 인크. Bet 억제제로서의 헤테로시클릭 화합물
EP4558501A1 (en) * 2022-07-20 2025-05-28 Arcus Biosciences, Inc. Cbl-b inhibitors and methods of use thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002003370A (ja) * 1999-09-20 2002-01-09 Takeda Chem Ind Ltd メラニン凝集ホルモン拮抗剤
US20020099073A1 (en) * 2000-07-07 2002-07-25 Andersen Henrik Sune Modulators of protein tyrosine phosphatases (PTPases)
GB0124627D0 (en) * 2001-10-15 2001-12-05 Smithkline Beecham Plc Novel compounds
US20060194871A1 (en) * 2003-04-11 2006-08-31 Barvian Kevin K Heterocyclic mchr1 antagoists
JP2007509158A (ja) * 2003-10-23 2007-04-12 グラクソ　グループ　リミテッド 肥満、糖尿病、うつ病及び不安を治療するためのｍｃｈｒ１アンタゴニストとしての３−（４−アミノフェニル）チエノピリミド−４−オン誘導体
US20050176738A1 (en) * 2003-11-07 2005-08-11 Neurocrine Biosciences, Inc. Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
RU2358969C2 (ru) * 2004-02-13 2009-06-20 Баниу Фармасьютикал Ко., Лтд. Конденсированное 4-оксопиримидиновое производное
WO2005103039A1 (en) * 2004-04-15 2005-11-03 Neurocrine Biosciences, Inc. 2- (3-aminopyrrolidin-1-yl) pyridines as melanin-concentrating hormone receptor an tagonists
ES2315877T3 (es) 2004-06-18 2009-04-01 Biolipox Ab Indoles utiles en el tratamiento de inflamaciones.
WO2006066174A1 (en) * 2004-12-17 2006-06-22 Eli Lilly And Company Thiazolopyridinone derivates as mch receptor antagonists
WO2007093364A1 (en) * 2006-02-15 2007-08-23 Sanofi-Aventis Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
KR20080094699A (ko) * 2006-02-15 2008-10-23 사노피-아벤티스 신규 아미노알콜-치환된 아릴디하이드로이소퀴놀리논, 이의제조 방법 및 이의 약물로서의 용도

Similar Documents

Publication Publication Date Title
JP2009539875A5 (cg-RX-API-DMAC7.html)
US11485745B2 (en) Amido spirocyclic amide and sulfonamide derivatives
ES2985528T3 (es) Nuevos compuestos y composiciones farmacéuticas de los mismos para el tratamiento de enfermedades
FI3932919T3 (fi) Jak-inhibiittoriyhdiste ja sen käyttö
ES2441017T3 (es) Compuesto de pirazolo[1,5-A]pirimidina como antagonista del receptor CB1
ES2993440T3 (en) Heterocyclic derivatives and use thereof
US12606554B2 (en) Compounds and pharmaceutical compositions thereof for the treatment of diseases
JP2013523889A5 (cg-RX-API-DMAC7.html)
PT1539753E (pt) Compostos de pirazolo(3,4-b)piridina e sua utilização como inibidores da fosfodiesterase
WO2005117890A3 (en) Thienopyrimidines and thiazolopyrimidines for use in medicine
JP2004520324A5 (cg-RX-API-DMAC7.html)
CA2650290A1 (en) Pharmaceutical compounds
NZ582352A (en) Pyrimidine derivatives useful as raf kinase inhibitors
WO2000047558A1 (en) Amide compounds and medicinal use thereof
NZ553886A (en) Piperidinylamino-thieno[2,3-D] pyrimidine compounds
JP2013539789A5 (cg-RX-API-DMAC7.html)
JP7597709B2 (ja) 置換インドールおよびインダゾール化合物
RU2612251C2 (ru) Соединения диоксин- и оксазин[2,3-d]пиримидина в качестве ингибиторов фосфоинозитид-3-киназы и способы их применения
HRP20160725T1 (hr) Biciklični heterociklični derivati kao inhibitori fgfr kinaze za primjenu u terapiji
WO2013127266A1 (en) Amido-benzyl sulfone and sulfoxide derivatives
JP2015524450A5 (cg-RX-API-DMAC7.html)
JP2013502396A5 (cg-RX-API-DMAC7.html)
IL305843B2 (en) CSF-1R receptor antibodies
JP2010532387A5 (cg-RX-API-DMAC7.html)
JP2017531672A5 (cg-RX-API-DMAC7.html)